1. Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient 
Patrick Stiff, Ivana Micallef, Philip McCarthy, Margarida Magalhaes-Silverman, Daniel Weisdorf, Mary Territo, Karin Badel, Gary Calandra 
Biology of Blood and Marrow Transplantation 
Volume 15, Issue 2, Pages (February 2009)
DOI: /j.bbmt
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Mobilization schema.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Number of apheresis days to reach cell count target of 5 × 106 CD34/kg for all patients, and the non-Hodgkin's and MM subsets.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Number of apheresis day to reach CD34 cell target of 5 × 106 CD34/kg for heavily versus nonheavily pretreated patients.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions